kabutan

DAIICHI SANKYO COMPANY, LIMITED(4568) Summary

4568
TSE Prime
DAIICHI SANKYO COMPANY, LIMITED
2,818.5
JPY
-81.5
(-2.81%)
Mar 13, 3:30 pm JST
17.68
USD
Mar 13, 2:30 am EDT
Result
PTS
outside of trading hours
2,832
Mar 13, 11:51 pm JST
Summary Chart Historical News Financial Result
PER
17.9
PBR
3.02
Yield
2.77%
Margin Trading Ratio
13.74
Stock Price
Mar 13, 2026
Opening Mar 13, 9:01 am
2,850.0 JPY 17.91 USD
Previous Close Mar 12
2,900.0 JPY 18.24 USD
High Mar 13, 9:05 am
2,867.5 JPY 18.02 USD
Low Mar 13, 10:49 am
2,805.5 JPY 17.61 USD
Volume
11,552,000
Trading Value
0.03T JPY 0.21B USD
VWAP
2831.96 JPY 17.77 USD
Minimum Trading Value
281,850 JPY 1,768 USD
Market Cap
5.34T JPY 0.03T USD
Number of Trades
17,899
Liquidity & Number of Trades
As of Mar 13, 2026
Liquidity
High
1-Year Average
9,746
1-Year High Jan 30, 2026
50,451
Margin Trading
Date Short Interest Long Margin Positions Ratio
Mar 6, 2026 128,500 8,798,400 68.47
Feb 27, 2026 145,200 7,850,800 54.07
Feb 20, 2026 158,000 8,677,200 54.92
Feb 13, 2026 149,500 8,382,200 56.07
Feb 6, 2026 151,300 8,666,000 57.28
Company Profile
DAIICHI SANKYO COMPANY, LIMITED is a major pharmaceutical company in Japan, with strengths in cardiovascular and infectious diseases. The company has partnered with AstraZeneca of the UK for new cancer drugs.
Sector
Pharmaceuticals
DAIICHI SANKYO COMPANY, LIMITED primarily engages in the research, development, manufacturing, and sales of pharmaceuticals, with a broad range of operations both domestically and internationally. In Japan, the company operates through multiple subsidiaries involved in pharmaceutical manufacturing, research and development and sales of over-the-counter drugs, and vaccine research, development, and production, showcasing a diverse group of companies with varied functions. The company has partnered with AstraZeneca in the oncology field. Internationally, DAIICHI SANKYO has subsidiaries in the United States, Europe, China, Brazil, and other regions, conducting pharmaceutical research, development, manufacturing, and sales in each area. In the United States, the company has established a holding company, while in Europe, it operates through numerous group companies across various countries. DAIICHI SANKYO leverages its global network for research, development, manufacturing, and sales to enhance its competitiveness in the world market.